Trial Profile
Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose Tolerance [glucose intolerance]
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 29 Aug 2023
Price :
$35
*
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Coronary artery disease; Glucose intolerance
- Focus Pharmacodynamics
- 27 Aug 2008 New trial record.